• SENSEX
    NIFTY 50
big story

We will now begin a new journey to build a new India, says Narendra Modi

272/543
L :0
W :353
L :0
W :92
NDA :353
UPA : 92
LOK SABHA ELECTION RESULTS 2019
Total Constituencies
543
Voter Turnout
67.11%
NDA : 353
2014 : 354 Seats
BJP
303
+
SS
18
+
Other
32
UPA : 92
2014 : 66 Seats
INC
52
+
DMK
23
+
Other
17
OTH : 97
2014 : 107 Seats
TMC
22
+
YSRCP
22
+
Other
53
Market

Top stocks to watch out for on May 8: Vedanta, Biocon, Zee, RCom, Yes Bank

Updated : May 08, 2019 07:55 AM IST

Indian shares are set for a negative start on Wednesday following losses in global markets after trade tensions between the US and China escalated. Shares in Asian and the US fell sharply as the latest developments in the US-China trade conflict fanned fresh fears about global growth. The US on Monday accused Beijing of backtracking from commitments made during trade negotiations. Indian investors are cautious ahead of Lok Sabha election results due on May 23. In the previous session, benchmark indices BSE Sensex and NSE’s Nifty 50 plunged nearly 1 percent. Here are the top stocks to watch out for in today’s trade:

Vedanta: The mining giant reported a 33.8 percent decline in consolidated net profit to Rs 2,615 crore for the March quarter, compared to Rs 3,956 crore in the corresponding quarter last year. The company's consolidated income declined by 12 percent to Rs 25,096 crore in the quarter. (Image: Reuters)
Vedanta: The mining giant reported a 33.8 percent decline in consolidated net profit to Rs 2,615 crore for the March quarter, compared to Rs 3,956 crore in the corresponding quarter last year. The company's consolidated income declined by 12 percent to Rs 25,096 crore in the quarter. (Image: Reuters)
Biocon: The pharma major retained its economic interest in the global commercialisation of Hulio in-licensed by Mylan. 
Biocon: The pharma major retained its economic interest in the global commercialisation of Hulio in-licensed by Mylan.  "Following the successful approval and European launch of Hulio, (biosimilar Adalimumab) in-licensed by our partner Mylan from Fujifilm Kyowa Kirin Biologics, the commercialisation rights have been extended from Europe to global markets," it said in a regulatory filing. (Image: Reuters)
Zee Entertainment: Essel Group on Tuesday said the stake sale process of Zee Entertainment Enterprises is at an advanced stage. The group cannot share any additional details at this stage due to confidentiality agreements, it added. (Stock Image)
Zee Entertainment: Essel Group on Tuesday said the stake sale process of Zee Entertainment Enterprises is at an advanced stage. The group cannot share any additional details at this stage due to confidentiality agreements, it added. (Stock Image)
Reliance Communications: RCom lenders moved NCLT to appoint a new resolution professional and form a committee of creditors, the first step to begin the bankruptcy process of the Anil Ambani group company that owes close to Rs 50,000 crore to 31 lenders led by State Bank of India. (Image: Reuters)
Reliance Communications: RCom lenders moved NCLT to appoint a new resolution professional and form a committee of creditors, the first step to begin the bankruptcy process of the Anil Ambani group company that owes close to Rs 50,000 crore to 31 lenders led by State Bank of India. (Image: Reuters)
Mindtree: The IT firm informed stock exchanges that around 1.10 crore pledged shares of the company were released on March 30, following instructions from various debenture holders. The shares were pledged by Coffee Day Enterprises.. (stock image)
Mindtree: The IT firm informed stock exchanges that around 1.10 crore pledged shares of the company were released on March 30, following instructions from various debenture holders. The shares were pledged by Coffee Day Enterprises.. (stock image)
Ceat: The tyre maker reported a 16.26 percent fall in its consolidated net profit to Rs 64.32 crore for the fourth quarter ended March 31, as against a net profit of Rs 76.81 crore last year. Revenue from operations, however, rose to Rs 1,760.47 crore for the fourth quarter as against Rs 1,686.09 crore in the year-ago quarter. (Stock Image)
Ceat: The tyre maker reported a 16.26 percent fall in its consolidated net profit to Rs 64.32 crore for the fourth quarter ended March 31, as against a net profit of Rs 76.81 crore last year. Revenue from operations, however, rose to Rs 1,760.47 crore for the fourth quarter as against Rs 1,686.09 crore in the year-ago quarter. (Stock Image)
Bharti Airtel: The telecom operator and Hughes Communications India Ltd (HCIL) said they will combine their VSAT satellite operations in the country, with Hughes holding a majority stake in the merged entity. Hughes will hold 67 percent stake in HCIL, the surviving entity, while Airtel will have 33 percent stake. (Image: Reuters)
Bharti Airtel: The telecom operator and Hughes Communications India Ltd (HCIL) said they will combine their VSAT satellite operations in the country, with Hughes holding a majority stake in the merged entity. Hughes will hold 67 percent stake in HCIL, the surviving entity, while Airtel will have 33 percent stake. (Image: Reuters)
Yes Bank: The private sector lender has acquired eight crore shares in electric equipment maker CG Power and Industrial Solutions which were pledged to it by a borrower. The acquired shares represent 12.79 percent ownership in the company and will be valued at Rs 292.56 crore as per Tuesday's close. (Image: Reuters)
Yes Bank: The private sector lender has acquired eight crore shares in electric equipment maker CG Power and Industrial Solutions which were pledged to it by a borrower. The acquired shares represent 12.79 percent ownership in the company and will be valued at Rs 292.56 crore as per Tuesday's close. (Image: Reuters)
Alembic pharma: The company has entered into a joint venture agreement with SPH SINE Pharmaceutical Laboratories Co Ltd and China & Adia (Shanghai) Pharma Co Ltd. The JV will commercialise products manufactured by Alembic Pharma. Subsequently, the JV plans to set up a manufacturing facility in China. (Stock Image)
Alembic pharma: The company has entered into a joint venture agreement with SPH SINE Pharmaceutical Laboratories Co Ltd and China & Adia (Shanghai) Pharma Co Ltd. The JV will commercialise products manufactured by Alembic Pharma. Subsequently, the JV plans to set up a manufacturing facility in China. (Stock Image)
Q4 Results: Titan, Tata Communications, Shriram Transport Finance, Chennai Petro, Alembic Pharma, Dhanlaxmi Bank, JSW Holding, KEC International, Gillette India, EID Parry, JK Paper, MAS financial, Rain Industries, Satin Creditcare, P&G Hygiene, JMC Projects, KSB LTD, Axiscades Engineering, CreditAccess Grameen, Dishman Carbogen, Shriram AMC, Saregama India, Kokuyo Camlin, Srikalahasthi Pipes, Emami paper. (Image: Reuters)
Q4 Results: Titan, Tata Communications, Shriram Transport Finance, Chennai Petro, Alembic Pharma, Dhanlaxmi Bank, JSW Holding, KEC International, Gillette India, EID Parry, JK Paper, MAS financial, Rain Industries, Satin Creditcare, P&G Hygiene, JMC Projects, KSB LTD, Axiscades Engineering, CreditAccess Grameen, Dishman Carbogen, Shriram AMC, Saregama India, Kokuyo Camlin, Srikalahasthi Pipes, Emami paper. (Image: Reuters)
Live TV

Ask Our Experts CNBC TV18

Send your queries on investments and have them answered by our experts

Enter your details

Post